Efficacy and safety of Guhong injection for treating coronary microvascular disease: study protocol for a randomized controlled trial
DiscussionThis trial is strictly designed in accordance with principles and regulations issued by the China Food and Drug Administration (CFDA). The results should provide high-quality evidence on the efficacy and safety ofGuhong injection in the treatment of CMVD.Trial registrationChinese Clinical Trials Registry, ID:ChiCTR1900022902. Registered on 27 April 2019.
Source: Trials - Category: Research Source Type: clinical trials
More News: Angiography | Cardiology | Cardiovascular | China Health | Clinical Trials | Coronary Heart Disease | Electrocardiogram | Food and Drug Administration (FDA) | Heart | Heart Disease | Research | Study